Publication Name	World Journal of Clinical Cases
Manuscript ID	63267
Country	Croatia

Received	2021-01-27 06:29
Peer-Review Started	2021-01-27 06:32
To Make the First Decision
Return for Revision	2021-02-25 21:47
Revised	2021-03-01 12:03
Second Decision	2021-05-27 12:03
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-05-27 12:14
Articles in Press	2021-05-27 12:14
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-05-31 21:16
Typeset the Manuscript	2021-06-21 06:26
Publish the Manuscript Online	2021-07-07 08:39

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Surgery
Manuscript Type	Minireviews
Article Title	Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy
Manuscript Source	Invited Manuscript
All Author List	Danko Mikulic and Anna Mrzljak
ORCID	Author(s) ORCID Number Danko Mikulic http://orcid.org/0000-0001-8103-6045 Anna Mrzljak http://orcid.org/0000-0001-6270-2305
Funding Agency and Grant Number
Corresponding Author	Danko Mikulic, FEBS, MD, PhD, Surgeon, Department of Surgery, University Hospital Merkur, Zajceva 19, Zagreb 10000, Croatia. danko.mikulic@zg.t-com.hr
Key Words	Pancreatic adenocarcinoma; Borderline resectable; Neoadjuvant therapy; Venous resection; Arterial resection; Vascular reconstruction
Core Tip	Curative treatment of pancreatic ductal adenocarcinoma is only possible after margin negative surgical resection. Borderline resectable pancreatic cancer is characterized by vascular tumor involvement and the need to perform vascular resection to achieve radical resection. This report reviewed the characteristics of borderline resectable pancreatic cancer and the current treatment perspectives, including aggressive surgical approaches in the era of neoadjuvant therapy.
Publish Date	2021-07-07 08:39
Citation	Mikulic D, Mrzljak A. Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy. World J Clin Cases 2021; 9(20): 5398-5407
URL	https://www.wjgnet.com/2307-8960/full/v9/i20/5398.htm
DOI	https://dx.doi.org/10.12998/wjcc.v9.i20.5398

Full Article (PDF)	WJCC-9-5398.pdf
Full Article (Word)	WJCC-9-5398.docx
Manuscript File	63267-Review-Filipodia CL.docx
Answering Reviewers	63267-Answering reviewers.pdf
Audio Core Tip	63267-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	63267-Conflict-of-interest statement.pdf
Copyright License Agreement	63267-Copyright license agreement.pdf
Peer-review Report	63267-Peer-review(s).pdf
Scientific Misconduct Check	63267-Scientific misconduct check.pdf
Scientific Editor Work List	63267-Scientific editor work list.pdf